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Effects of jaundiced plasma on.vascular sensitivity to noradrenalin.
Alterations in renal perfusion have been shown in a variety of liver
diseases.We have examined the possibility that the syndrome is due
to a renal vascular hypersensitivity to noradrenalin (NA). Isolated
perfused kidneys and segments of rabbit femoral artery were used.
Potentiation of the pressor effects of injected NA occurred in all
(five artery and five kidney) preparations when jaundiced baboon
plasma was perfused. These changes were significant (P K 0.05)
in nine out of the ten experiments. Controls to which normal ba-
boon plasma was administered showed no such change. No cor-
relation was found between the degree of NA potentiation and the
plasma concentrations of bilirubin (total and conjugated), serum
glutamic oxaloacetic transaminase, blood urea nitrogen, serum
glutamic pyruvic transaminase, alkaline phosphatase, Na ions or
K ions in the jaundiced plasma. Plasma renin levels were not
significantly changed. When arteries were perfused with Krebs
solution containing the -lipoprotein extract of jaundiced plasma,
a potentiation of NA was found. Perfusion of sodium taurocholate
or sodium deoxycholate (400 sg/ml) yielded no potentiation.
Thus, the altered renal perfusion associated with jaundice may be
attributed to a potentiated pressor response to NA which may be
caused by an increased level of cholesterol carried on the d-
lipoprotein.
Effetsduplasmaictériquesur Ia sensibilité vasculaire ala noradrén-
aline. Des modifications de La perfusion rénale ont été décrites
dans plusieurs affections hepatiques. Nous avons étudié Ia
possibilité que ce syndrome soit lie a une hypersensibilite
vasculajre rCnale a noradrénaline (NA). Des reins isolés
perfusés et des segments d'artères fémorales de lapin ont été
utilisés. Une potcntialisation des effets presseurs de NA injectée
a etC observCe dans toutes (cinq artCres et cinq reins) les prépara-
tions étudiées quand du plasma de babouin ictérique a été
perfuse. Ces modifications sont significatives dans neuf experiences
sur dix. Les contrôles réalisés avec du plasma de babouin
normal ne montrent pas ces modifications. Aucune correlation
na été trouvée entre Ia degre de potentialisation de NA et
Ia concentration plasmatique de bilirubine (totale ou conjuguée),
de SOOT. dazote non protéique, de SGPT de phosphatases
alcalines, de Na ou K du plasma ictérique. Les concentra-
tions plasmatiques de rénine n'étaient pas significativement
moditiées. Quand les artCres sont perfusées avec un Krebs
contenant Ia -lipoprotéine extraite du plasma ictérique une
potentialisation est observée. La perfusion de taurocholate de
sodium ou de deoxycholate de sodium (400 pg/mI) n'entraine pas
de potentialisation. Ainsi Ia diminution de Ia perfusion rénale peut
Ctre attribuée a une potentialisation de Ia réponse pressive a NA
peut Ctre Ia consequence d'une augmentation du cholesterol
transporte par Ia i3-lipoprotéine.
Alterations in renal perfusion associated with a
lowered glomerular filtration rate and oliguria have
been described in a variety of diseases involving the
liver [1-3]. Cirrhosis, for example, has been shown to
cause an increase in renal vascular resistance and a
decrease in glomerular filtration rate [I]. This posi-
tion may be improved by drugs which lower renal
vascular resistance, and it has been suggested that the
disturbance is primarily a hemodynamic one [4, 5]. A
high incidence of postoperative renal failure has also
been found in jaundice [6]. The cause of this renal
shutdown was suggested to be a vascular hypersen-
sitivity during periods of hypotension [7].
As sustained hypotension is associated with an in-
creased sympathetic discharge and elevated con-
centrations of circulating catecholamines [8], it is
possible that the cause of renal vascular changes dur-
ing jaundice may be a potentiated pressor response to
noradrenalin (NA). We have examined this pos-
sibility.
As it has been suggested that the renal hypersen-
sitivity to hypotension is due to an elevated plasma
bile salt concentration [9], we have examined the
responses of our preparation to NA when bile salts
were perfused.
Also, Salt and Iversen [10] have shown that
cholesterol inhibits NA uptake into heart muscle and
that this inhibition leads to a larger amount of free
NA. As circulating cholesterol concentrations in-
crease during jaundice [11], it is possible that a
similar increase in free NA in the arterial muscle
could produce a potentiated pressor response to the
NA. Since most of the cholesterol is carried on the f3-
lipoproteins, we have examined the responses of
isolated arteries to NA when /3-lipoprotein extracted
from jaundiced plasma was perfused.
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Methods
The arterial model used to assay the vasoconstric-
tor effect of NA was similar to that used by De La
Received for publication November 13, 1974; and in revised
form April 7, 1975.
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Lande and Rand [13]. The technique involved the
measurement of perfusion pressure in a constant flow
system. Two preparations were used in different ex-
periments, the isolated perfused artery segment and
the perfused kidney.
New Zealand white rabbits were anesthetized i.v.
with pentobarbital sodium. Then either a kidney or a
femoral artery was exposed. The preparation was
cannulated proximally, removed from the animal,
washed through with a heparinized Krebs solution
and then perfused using a constant flow peristaltic
pump (LKB 12000) with Krebs solution at 37°C. The
organ bath was also maintained at 37°C temperature
using an outer thermostatically controlled water
jacket. The Krebs solution contained, in mmoles/liter,
the following: NaCI, 118.0; KCI, 4.69; NAH2PO4,
1.33; NaHCO3, 25.0; glucose, 5.56; CaCI2, 2.52; and
MgCI2, 1.05. All perfused solutions were maintained
at pH = 7.40 and constant Pco2 and P02 by bubbling
a gas containing 6% CO2 and 94% 02 through the
perfusate reservoir. Perfusion pressure was moni-
tored using a transducer (Statham P 23 BB) con-
nected to the flow system via a T tube, and the
perfusion rate was kept constant throughout each ex-
periment at 4 to 5 ml/min. This rate yielded inflow
pressures 80 to 85 mm Hg in the kidney experiments
and 5 to 10 mm Hg in the artery experiments.
The arterial constrictor responses to NA were
determined by injecting graded doses of NA in
warmed Krebs as a bolus into the perfusate just prox-
imal to the preparation. The resultant changes in ves-
sel caliber and resistance were monitored as the
amplitude of change in perfusion pressure and
recorded on a dynograph (Beckman).
The system was allowed to stabilize for at least 30
mm during perfusion with Krebs solution. Then a
series of responses to graded NA doses was obtained.
The perfusate was then changed to plasma which had
been removed from one of ten baboons with surgical-
ly induced obstructive jaundice. All of the animals
were jaundiced for two weeks and the plasma was
stored in a freezer until it was used. This was allowed
to perfuse for 60 mm and then a further series of
responses to NA was determined. The perfusate was
again changed to Krebs and 60 mm later another
series of responses was obtained. In all plasma sam-
ples the plasma renin, total and conjugated bilirubin,
blood urea nitrogen, alkaline phosphatases, trans-
aminases and sodium and potassium concentrations
were measured.
Five experiments using kidneys and five using fem-
oral arteries were carried out plus a similar number
of controls with each preparation using nonjaundiced
plasma from sham-operated baboons.
/3-lipoproteins. Plasma was removed from a further
five fasting baboons which had been jaundiced for
two weeks. These samples were spun in an
ultracentrifuge (Beckman C265B) at 19,000 rpm for a
period of 30 mm to remove the chylomicrons. Then
the samples were spun at 40,000 rpm for 18 hr with a
density solution containing 11.4 g of NaCI, 0.1 g of
Na2 EDTA and 1 ml of N/liter of NaOH made up to
1 liter with distilled water and of specific gravity
1.006. Pre-3-lipoproteins moved from plasma into
this solution and were removed. The remaining
plasma was further spun at 40,000 rpm for 20 hr with
a second density solution containing 24.98 g of NaBr
in 100 ml of the first density solution and of specific
gravity 1.182. The 3-lipoproteins moved from plasma
into this solution and their presence was confirmed
with the use of an autoanalyzer (Technicon A 11) as
well as by electrophoresis. The 3-1ipoproteins were
then dialyzed against normal saline for 24 hr to
remove the EDTA and bromide. This lipoprotein
solution was diluted back to its original plasma con-
centration using Krebs solution and this was infused
into an artery. Five experiments were carried out plus
an equal number of controls using bovine albumen
(Merck), 50 to 250 mg/lOO ml. In addition, the
plasma remaining after /3-lipoprotein removal was
used in a further five experiments. Due to the paucity
of material, only ten minutes was allowed between
the start of protein perfusion and the construction of
the NA dose-response curves.
Bile salts. We have also investigated the effects of
two bile salts in six artery experiments.
Drugs used. Noradrenalin acid tartate (NL),
sodium deoxycholate (BDH) and sodium tauro-
cholate (BDH) were used.
Analysis of results. Two methods of analyzing these
results have been used.
a) Method 1. The dose-response data obtained in
each individual experiment were plotted as the in-
crease in perfusion pressure ("response-mm Hg")
against the logarithm of the dose (g of NA). This
produced three curves for each experiment, one for
the control (Krebs) perfusate, one for the jaundiced
plasma perfusate and one for the washout with Krebs
solution. The straight line portion of each curve was
identified and regression lines were calculated.
Figure 1 shows the method for quantifying the
changes in sensitivity during an experimental period.
For each response R1 a lower dose of NA was re-
quired during the jaundiced plasma perfusion period
than for the first Krebs period. Thus, by calculating
the ratio of these doses, Krebs/experimental, a value
of greater than 1 was obtained. A number of these
ratios were calculated in each experiment for
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Fig. 1. Analysis of data—method I. Idealized regression lines of
response (mm Hg) plotted against log/dose of NA (pg) are shown
for one experiment. The sensitivity ratios are calculated by the
ratio of dose of NA (Krebs) to the dose of NA (experimental) re-
quired to produce the same response. An example is shown at
response R1.
responses at fixed intervals along the linear portions
of the dose-response curves. The mean of these ratios
was then calculated for each experiment. Also, the
significance of any deviation of the observed ratio
from 1 was calculated by comparing the doses
(Krebs) and doses (experimental) in each single ex-
periment using a paired t test.
b) Method 2. The dose-response data obtained in
each individual experiment were plotted as the
reciprocal of the perfusion pressure increase (1/
response, mm Hg) against the reciprocal of the dose
(1/dose of NA, 1g). This produced straight line
relationships in each experiment as predicted from
the Michaelis-Menten kinetics for drug-receptor in-
teraction [14].
R — Rmar D Rmax
where R = response (mm Hg), D = NA dose (tg);
Rmax = maximal response (mm Hg) and Keq =
equilibrium coefficient for drug-receptor interaction.
In each experiment, values of Rmax and Keq were
calculated from the intercepts of the line on the x and
y axes, respectively, as shown in Fig. 2. When l/D is
zero, l/R (y intercept) is equal to l/Rmax. When l/R
is zero, then 1/D (x intercept) is equal to — 1/Keq.
Changes in 1/Rmax imply changes in the intrinsic ac-
tivity of the drug-receptor complex, while changes in
1/Keq imply changes in drug-receptor affinity.
[Dl
Fig. 2. Analysis of data—method 2. This shows an idealized regres-
sion line of reciprocal of response (l/R) plotted against reciprocal
of dose of NA (l/D). The maximum response (Rmx) may be
measured from the intercept on the y axis and the equilibrium
coefficient (Kea) from the interception on the x axis.
Results
Jaundiced plasma perfusion. Figure 3 shows three
sets of responses obtained from a perfused kidney.
NA concentration ISensitivity ratio at response R1 = NA concentration 2
R1—.-
E
00
I)
R
Rmax
Keq
Krebs
NA,pg 1.6 6.4 6.4 1.6
Jaundiced
plasma
NA,pg 1.6 6.4 6.4 1.6 0.64 0.16
Washout
NA,pg 0.16 0640.8
—5 min- 250mm HgI
Fig. 3. Isolated kidney—experimental. Three traces of perfusion
pressure are shown. The top trace shows the responses as changes
of perfusion pressure (mm Hg) when several doses of NA were
injected during perfusion with Krebs solution. The middle trace
shows similar responses when jaundiced plasma was perfused,
and the bottom trace, those obtained during reperfusion with
Krebs. A time scale (mm) and a pressure calibration (10 mm Hg)
are also shown. It can be seen that NA responses are potentiated
by jaundiced plasma.
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Fig. 4. Kidney log dose/responses—experimental. This graph shows
kidney responses in mm Hg (y axis) plotted against the doses of in-
jected NA (x axis). The closed circles show the responses obtained
to NA when Krebs was initially perfused. The open circles show
those obtained when the jaundiced plasma was perfused and the
open triangles show those when Krebs was reperfused. It can be
seen that jaundiced plasma shifts the curve to the left.
The top trace shows the pressure changes in the per-
fusate after injection of doses of NA ranging from 0.8
to 8.0 sg. The middle trace shows the pressure
changes after injection of NA when the kidney was
perfused with jaundiced plasma and the bottom trace
shows the responses after a period of washout with
Krebs solution. It is clear that the responses to NA
are much larger in the presence of jaundiced plasma.
When the plasma was replaced with the Krebs solu-
tion, the NA sensitivity of the preparation returned
towards normal. Similar results were found for the
kidney experiments and the five femoral artery ex-
periments.
Figure 4 shows a response/log dose plot of the data
from a typical kidney experiment. It can be seen that
the jaundiced plasma caused the dose-response curve
to shift to the left of the control (Krebs) curve in-
dicating that a potentiation of the effects of NA had
occurred. In order to produce an increase of 50 mm
Hg in perfusion pressure, approximately 1 eg of NA
was needed when the perfusate was Krebs solution.
When the jaundiced plasma was perfused, only about
0.5 tg of NA produced the same response, giving a
"sensitivity ratio" of about 2. When the plasma was
washed out of the preparation with the Krebs solu-
tion, the dose-response curve shifted back towards
the initial curve, showing that the changes with jaun-
diced plasma are not due to an increased vascular
sensitivity with time.
An example of a control experiment using normal
Dose of NA, pg
Fig. 5. Kidney log dose/responses—control. This graph shows the
responses obtained during Krebs perfusion (closed circles) and
during normal plasma perfusion (open circles). No potentiation
occurred.
baboon plasma is shown in Fig. 5. No significant
potentiation occurred in this example or in any of the
other controls. The isolated perfused arteries showed
the same type of response to jaundiced and control
plasma as the kidneys.
When several sensitivity ratios per experiment were
calculated, a mean value could be obtained for each
individual experiment. These results from five artery
experiments and five kidney experiments with jaun-
diced plasma, together with the normal plasma con-
trols, are shown in Table 1. In all experiments on
both arteries and kidneys, the mean sensitivity ratio
was greater than 1. In all but one artery experiment,
these changes were found to be significant (P < 0.05).
Arteries Kidneys
Expert- Mean Experi- Mean
ment sensitivity ment sensitivity
No. ratio P No. ratio P
I
Jaundiced plasma experiments
9.7 <0.05 I 3.96 <0.05
2 1.98 NS 2 5.21 <0.05
3 6.57 <0.05 3 3.14 <0.05
4 6.17 <0.05 4 5.33 <0.05
5 10.09 <0.05 5 4.32 <0.05
Normal plasma controls
I 0.58 NS 1 1.05 NS
2 0.41 NS 2 1.35 NS
3 1.28 NS 3 1.87 NS
4 0.93 NS 4 0.43 NS
Kidney
150 • Krebs
o Jaundiced plasma
Washout 0
Kidney
• Krebs
o Normal plasma
100
8
CCC' 50
8
8
CCC'
150
100
50 -
0
0.08 0.8 8 0.08 0.8 8
Table 1. Mean sensitivity ratios calculated in each experiment
and each control together with the significance of the ratio's
deviation from I
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Dose
Fig. 6. Artery double reciprocal—experimental. This graph shows
the reciprocals of the responses of an artery in mm Hg (y axis) plot-
ted against the reciprocal of the doses of injected NA (x axis). The
closed circles show the responses obtained to NA when Krebs
was initially perfused. The open circles show those obtained when
jaundiced plasma was perfused. The intercept on the x axis can
be seen to be altered.
There was no significant increase in sensitivity ratio
in any of the controls.
Table 2 shows the results of the biochemical in-
vestigations carried out on all of the plasma samples
used. No correlation could be found between the
degree of NA sensitivity change (size of sensitivity
ratio) and the degree of jaundice (bilirubin, mg/l00
ml), blood urea nitrogen concentration (BUN),
the concentrations of transaminases, alkaline
phosphatase, Na" ions or K"' ions. In addition, there
was no consistent relationship between plasma renin
activity and the sensitivity ratio. Plasma renin activity
was not determined in any of the isolated kidney ex-
periments or kidney controls. All plasma renin assays
were carried out in the baboons prior to exsanguina-
tion.
Figure 6 shows a reciprocal plot of the data from a
typical femoral artery experiment. It can be seen that
both the slope and x intercept of the line obtained
with Krebs perfusion are different from those during
jaundiced plasma perfusion, whereas the y intercepts
were virtually unchanged. Thus, the maximum
response (Rmax) of this artery has remained the same
while there was a large change in the equilibrium
coefficient (Keq).
Table 3 shows the values of Keq and Rmax
calculated in all experiments and controls both dur-
ing Krebs and during plasma perfusion. With the use
of a paired t test, the Keq (jaundiced plasma) was
found to be significantly different (P <0.05) from the
Keq (Krebs) in the artery and kidney experiments.
Although there was a tendency for Rmax to increase
when jaundiced plasma was used, this change was
not significant. Furthermore, there was no significant
change in either Keq or Rmax when normal plasma
was perfused. These results show that perfusion with
Table 3. The equilibrium coefficients (keq) and the maximum possible responses (Rmex) calculated for each experiment and each control
before and after the introduction of plasma to the preparation"
Arteries Kidneys
Krebs plasma
Rmax
Experiment
After No.
Krehs plasma
Experiment
No.
K eq Keq Rmax
Before After Before Before After Before After
I 2.51 1.54 7.63
Jaundiced plasma experiments
12.90 1 30.0 1.20 100.0 200.0
2 7.06 5.53 12.19 12.66 2 0.14 2.67 11.6 16.7
3 0.96 0.32 10.60 14.70 3 1.50 0.00 50.0 0.0
4 1.87 0.06 9.01 5.05 4 9.00 0.05 500.0 526.0
5 1.54 0.11 20.80 21.70 5 4.37 0.67 125.0 111.0
Mean 2.79
P < 0.05
1.51 12.05 13.4 Mean
NS
9,00
P < 0.05
0.92 157.3
NS
170.7
I 0.92 0.61 9.80
Normal plasma controls
4.97 1 1.17 1.00 166.7 100.0
2 1.99 1.74 4.08 2.00 2 5.33 1.58 166.7 83.3
3 0.71 0.41 5.46 5.95 3 2.80 3.80 55.5 166.7
4 14.90 9.20 12.34 7.94 4 6.40 1.25 200.0 125.0
Mean 4.63
NS
2.99 7.92 5.22 Mean
NS
3.93
NS
1.91 147.2
NS
118.7
aThe significance of any change is shown at the base of each column and is the result of a paired t test between Krebs
and the plasma used.
• Krebs
0 Jaundiced plasma
0.1
0 10
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jaundiced plasma potentiates the response of both the
isolated perfused kidney and artery to infused NA,
and that this change is mediated by a modified
equilibrium coefficient rather than by the tissues'
maximum response.
13 -1 ipoprotein perfusion. Figure 7 shows one experi-
ment in which an isolated artery was perfused with
1.4 mg/mI of 13-lipoprotein in Krebs solution. A
potentiation of the response to NA can be seen with
perfusion of the lipoprotein. No washout was at-
tempted in these experiments as our previous data
indicate that over this period of time no temporal
change in the tissue occurs and, thus, the potentia-
tion of NA ten minutes after addition of the 13-
lipoprotein is unlikely to be a temporal effect. This
potentiation of NA after the addition of /3-lipoprotein
occurred in all five experiments and was significantly
different in each (P < 0.001). No potentiation oc-
curred when bovine albumin was perfused. When
the plasma remaining after removal of pre-/3 and
/3-lipoproteins was perfused, a small degree of po-
tentiation was found in each of the experiments
performed (P < 0.05).
Bile salts. No consistent potentiation was observed
in any of three experiments using sodium
taurocholate and in three experiments using sodium
deoxycholate. Thus, the bile salts appear to play lit-
tle, if any, part in the potentiation of vascular
responses to injected NA in the presence ofjaundiced
plasma.
Discussion
The evidence presented in this paper provides a
possible explanation for the renal vascular changes
associated with obstructive jaundice [6-7, 17].
Analysis of the data by method 1 (log dose/response
plotting) shows that jaundiced plasma contains some
factor (or factors) which shifts the curve to the left.
Vascular sensitivity to NA is thus increased. The se-
cond method of analysis (reciprocal dose/reciprocal
response plotting) is more useful in suggesting a phar-
macokinetic basis for this potentiation [14]. An in-
creased maximal response (Rmax, derived from the y
intercept of the reciprocal dose-response curve)
would imply increased intrinsic activity of the drug.
This could occur by increasing the number of
available receptors or by potentiating the action of
the drug-receptor complex. In our experiments the y
intercept was not significantly changed, suggesting
that there was no change in the intrinsic activity of
the drug. However, the significant change in the x in-
tercept was due to a decrease in the equilibrium
coefficient (Keq) for the drug-receptor interaction.
Krebs 8.320.8 3.2 8.0pg of NA 1.6 6.4 6.4 1.6 64
This is consistent with either an increase of the affi-
nity of the receptor for the drug or of the concentra-
tion of the drug available for combination.
Epstein et al [15] have suggested that the changes
in renal perfusion which accompany cirrhosis are due
to active vasoconstriction. Our results support this
hypothesis and suggest that the etiologic factor
behind this vasoconstriction is an increased sen-
sitivity to NA. It has been suggested [9] that the
kidney is sensitized to periods of hypotension by cir-
culating bile salts. We have found no potentiation
with sodium taurocholate or sodium deoxycholate.
We have also found that the degree of potentiation
has no correlation with the concentrations of plasma
bilirubin (total and direct), BUN, the transaminases,
alkaline phosphatase, Na ions or K ions. In addi-
tion, there was no significant alteration in plasma
renin concentrations of our jaundiced plasma sam-
ples which were taken from the living animal. Thus, it
would appear that some other factor is responsible.
It has been shown that estrogens and cor-
ticosteroids inhibit the extraneuronal uptake of NA
into vascular muscle [16]. When this process is in-
hibited, more NA becomes available at the receptor
site, thereby causing an increase in the rate of drug-
receptor complex formation, and a reduction in Keq.
Since the metabolism of sex steroids by the liver is
reduced in hepatocellular failure [11], an increase in
the plasma steroid concentration would be an attrac-
tive hypothesis to explain the effect of the jaundiced
plasma on the action of NA.
Salt and Iverson [10] have demonstrated that free
cholesterol dissolved in ethanol is capable of in-
Krebs +
0.16 1064 1.
pgofNA 0.32 0.8 3:2 3:2 1.6
5 min—-
0.8
40cm H20
Fig. 7. Isolated artery—(3-lipoprotein. Pressure responses to injected
NA are shown during Krebs perfusion (top trace) and during per-
fusion of Krebs + 1.4 mg/mI of-1ipoprotein which was removed
from a jaundiced plasma sample (bottom trace). A potentiation of
the responses to NA can be seen.
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hibiting the uptake of 3H-noradrenalin into heart
muscle. If the protein-bound cholesterol found in
plasma is also capable of inhibiting this uptake, then
a potentiation of the effects of NA would be expected
during jaundice. Our work has shown that the
protein-bound cholesterol removed from jaundiced
plasma does potentiate NA and thus the elevation of
plasma cholesterol found in jaundice may be the
main factor producing the potentiation. The small
potentiation found when plasma minus the 3-
lipoprotein was perfused may be caused by the
remaining cholesterol on the a-lipoproteins or the
other plasma steroids. These may also increase in
jaundice and may contribute to the potentiation,
although some other factor in the plasma may be in-
volved.
It could be argued that a perfused isolated kidney
behaves differently than an intact kidney, but similar
results have been found in eivo [17]. Renal blood flow
was measured using the '33xenon clearance technique
in normal and jaundiced baboons. Similar changes in
resting perfusion were found as in other liver diseases
in man [1-3]. In addition, the jaundiced animals dis-
played a vascular hypersensitivity to infused NA.
Here, even under conditions where the kidney is sub-
ject to nervous and humoral influences, the vascular
response to NA seems to be potentiated by some fac-
tor or factors in the plasma of jaundiced animals.
Potentiation of responses to NA in the isolated
perfused rabbit ear artery have been shown when
Krebs was replaced with rabbit plasma or whole
blood [18]. This was suggested to be due to the in-
teraction between 5-hydroxytryptamine (which is
present in large amounts in rabbit plasma) and the in-jected NA. Since enzymes responsible for 5-
hydroxytryptamine (5-HT) breakdown are present in
the liver [19], it is possible that an increase in the level
of circulating 5-HT could also explain our results.
However, 5-HT in other species is normally carried in
the platelet fraction of the blood [20] with little or
none in the plasma. Thus, significant amounts of 5-
HT are unlikely to be present in our samples ofjaun-
diced plasma although we have not measured this
directly. Our additional experiments suggest that
removal of the lipoprotein fraction from the jaun-
diced plasma attenuates the potentiation. This would
suggest that 5-HT has no part in the phenomenon.
.lt could here be argued that we have used doses of
NA which are unlikely to be found in vivo. Although
we administered high doses of NA at the injection
site, it is likely that the actual concentration reaching
the preparation was considerably diluted by the per-
fusate; but we were unable to measure this.
In conclusion, our results would suggest that the
altered renal perfusion found during obstructive
jaundice [6-7, 17] may be due (at least in part) to a
vascular hypersensitivity to circulating NA. This NA
hypersensitivity may provide an explanation for the
renal failure found postoperatively in obstructive
jaundice. It has, however, been shown [15] that in cir-
rhosis sympathetic blockade does not improve renal
perfusion. It may be that the etiologic factors of renal
failure in these two conditions are fundamentally
different. In addition, the blockade attempted by
Epstein et al was accompanied by systemic hypoten-
sion. Baldus (1970) [21] has shown that renal blood
flow increased with the administration of phenoxy-
benzamine hydrochloride (Dibenzyline) if this
systemic hypotension was prevented by expansion
of plasma volume. It may be that even in cirrhosis an
increased NA sensitivity plays a part in altered renal
hemodynamics. Finally, our work would suggest
that the /3-lipoprotein elevation found in obstructive
jaundice may be one of the factors producing this
hypersensitivity to noradrenalin.
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